Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice
- 30 September 2006
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 201 (1), 120-130
- https://doi.org/10.1016/j.expneurol.2006.03.028
Abstract
No abstract availableKeywords
Funding Information
- Amyotrophic Lateral Sclerosis Association
- National Institutes of Health (RO1NS041680)
This publication has 36 references indexed in Scilit:
- β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expressionNature, 2005
- Glutamate transporters: animal models to neurologic diseaseNeurobiology of Disease, 2004
- Altered expression of the glutamate transporter EAAT2b in neurological diseaseAnnals of Neurology, 2004
- Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in miceHuman Molecular Genetics, 2003
- Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALSAnnals of Neurology, 2002
- ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing InclusionsNeuron, 1997
- Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortexAnnals of Neurology, 1996
- Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosisAnnals of Neurology, 1996
- Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosisAnnals of Neurology, 1995
- Localization of neuronal and glial glutamate transportersNeuron, 1994